Clinical Trial: A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442591) titled 'A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants' on Feb. 12.

Brief Summary: WD-1603 contains two different drugs called levodopa and carbidopa in one tablet. The goal of this clinical trial is to see if taking the study drug WD-1603 at different time intervals affects how the drug acts in healthy volunteers. We also want to learn about the safety of WD-1603.

The main question we want to answer is:

* How does the body process WD-1603 when it is taken by different time intervals? What will participants do?

* Participants will take one tablet of WD-...